Clinical Trial Update: Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating liraglutide's effect and action in diabetes with cardiovascular outcomes results completed; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2017-03-01